KLINGE PHARMA GMBH — Loperamide Importer Profile
Pharmaceutical Importer · #16 buyer for Loperamide · $530.3K import value · 42 shipments · GERMANY · DGFT Verified
KLINGE PHARMA GMBH is the #16 importer of Loperamide from India with $530.3K in import value and 42 verified shipments. KLINGE PHARMA GMBH holds a 0.6% market share in Loperamide imports based in GERMANY. The company sources from 1 verified supplier across 29 formulations shipped to 1 country.
KLINGE PHARMA GMBH — Loperamide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Loperamide to KLINGE PHARMA GMBH?
Verified from 42 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TENSHI KAIZEN PRIVATE LIMITED | $530.3K | 42 | 100.0% |
KLINGE PHARMA GMBH sources Loperamide from 1 verified Indian supplier based on 42 customs records. The primary supplier is TENSHI KAIZEN PRIVATE LIMITED accounting for 100.0% of imports.
How Does KLINGE PHARMA GMBH Compare to Nearest Loperamide Importers?
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | TILLOMED LABORATORIES LTD | UNITED KINGDOM | $489.8K | 28 | $17.5K |
| 15 | RX F L | UNITED KINGDOM | $475.2K | 44 | $10.8K |
| 16 | KLINGE PHARMA GMBH ★ | GERMANY | $470.8K | 39 | $12.1K |
| 17 | ASPEN PHARMACARE AUSTRALIA PTY LTD | AUSTRALIA | $465.0K | 27 | $17.2K |
KLINGE PHARMA GMBH ranks #16 among 1,005 Loperamide importers from India. Average shipment value of $12.1K compared to the market average of $11.2K. The closest competitors by value are TILLOMED LABORATORIES LTD and RX F L.
Where Does KLINGE PHARMA GMBH Import Loperamide To?
Destination countries from 42 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $530.3K | 42 | 100.0% |
KLINGE PHARMA GMBH imports Loperamide to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $530.3K.
What Loperamide Formulations Does KLINGE PHARMA GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12`S | $75.1K | 4 |
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12S | $70.6K | 5 |
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12`S47180 PAC | $48.2K | 1 |
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12`S30790 PAC | $31.5K | 1 |
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 6S Q | $28.8K | 1 |
| LOPERAMIDE HYDROCHLORIDE ORAL LYOPHILISATES 2MG 2X6 KLINGE GERMANY B N 1701967 MFG DT 04 25 EXP DT 03 2028 QTY 15750 PAC | $23.4K | 2 |
| LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12S( | $22.1K | 2 |
| LOPERAMIDE HYDROCHLORIDE ORAL LYOPHILISATES 2MG 2X6 KLINGE GERMANY B N 1701971 MFG DT 04 25 EXP DT 03 2028 QTY 7920 PAC | $20.6K | 2 |
| LOPERAMIDE HYDROCHLORIDE ORAL LYOPHILISATES 2MG 2X6 KLINGE GERMANY B N 1701968 MFG DT 04 25 EXP DT 03 2028 QTY 7920 PAC | $20.6K | 2 |
| LOPERAMIDE HYDROCHLORIDE ORAL LYOPHILISATES 2MG 2X6 KLINGE GERMANY B N 1701969 MFG DT 04 25 EXP DT 03 2028 QTY 7830 PAC | $20.3K | 2 |
KLINGE PHARMA GMBH imports 29 distinct Loperamide formulations from India. The top formulation is LOPERAMIDE HCL ORAL LYO KLINGE-GRMY 12`S with 4 shipments worth $75.1K.
Regulatory Requirements: Importing Loperamide into Germany
What KLINGE PHARMA GMBH and other importers must comply with to import Loperamide from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Loperamide
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Loperamide from India and How Much Does KLINGE PHARMA GMBH Import?
India exported $11.2M worth of Loperamide through 3,985 shipments from 305 suppliers to 128 countries, serving 1,005 buyers globally. KLINGE PHARMA GMBH imports $530.3K of this total, accounting for 0.6% of India's Loperamide exports with 42 shipments from GERMANY. This is verified from 42 customs shipment records covering 29 distinct formulations.
What Is the Average Order Value for KLINGE PHARMA GMBH's Loperamide Imports?
KLINGE PHARMA GMBH's average Loperamide order value is $12.6K per consignment, based on 42 shipments totaling $530.3K. KLINGE PHARMA GMBH is based in GERMANY and ranks #16 among all Loperamide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Loperamide to KLINGE PHARMA GMBH?
KLINGE PHARMA GMBH sources Loperamide from 1 verified Indian supplier: TENSHI KAIZEN PRIVATE LIMITED ($530.3K, 100.0%). This is based on 42 customs records.
How Does KLINGE PHARMA GMBH Compare to Other Loperamide Importers?
KLINGE PHARMA GMBH ranks #16 among 1,005 Loperamide importers from India with a 0.6% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES LLC ($2.4M), US PHARMACIA SP.ZO.O, ($1.1M), MEDREICH AUSTRALIA PTY LTD ($802.7K). KLINGE PHARMA GMBH processed 42 shipments from GERMANY.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Loperamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Loperamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: KLINGE PHARMA GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as KLINGE PHARMA GMBH's capped import value divided by total capped export value for Loperamide across all Indian exporters.
- 5.Verified Records: This page is backed by 42 individual customs records matching KLINGE PHARMA GMBH importing Loperamide, covering 29 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 128+ countries, 1,005+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Loperamide Import Data for KLINGE PHARMA GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for KLINGE PHARMA GMBH's Loperamide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
KLINGE PHARMA GMBH
Company Profile
Multiple products · $0 total trade · Multiple categories
KLINGE PHARMA GMBH × Loperamide
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for KLINGE PHARMA GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Loperamide. For current order-level data, contact TransData Nexus.